NCT00457405View on ClinicalTrials.gov

Does a Seven Day Treatment With Dipyridamole Induce Protection Against Ischemia-Reperfusion Injury?

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

October 31, 2007

Study Completion Date

March 31, 2008

Conditions
Ischemia-Reperfusion InjuryAtherosclerosis
Interventions
DRUG

dipyridamole

dipyridamole 200mg twice daily

Trial Locations (1)

6500HB

Radboud University Nijmegen Medical Centre, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT00457405 - Does a Seven Day Treatment With Dipyridamole Induce Protection Against Ischemia-Reperfusion Injury? | Biotech Hunter | Biotech Hunter